MyStonks data shows that Helius (HSDT), a US-listed company that recently announced its transformation into a SOL Treasury company, saw its stock surge 270% in pre-market trading. Notably, the company's previous closing price was just $7.56, with a market capitalization of just $8.14 million. Earlier news broke that Helius Medical Technologies (NASDAQ: HSDT) announced a major strategic transformation, transforming into a SOL Treasury company through a private equity investment exceeding $500 million. This PIPE (Private Equity Partnership), led by Pantera Capital and Summer Capital, was oversubscribed and included the sale of common stock at $6.881 per share and accompanying warrants at $10.134 each. If fully exercised, the warrants are expected to raise over $1.25 billion.